Terry J. Rosen, Chief Executive Officer at Arcus Biosciences, Inc. (RCUS), sold 109,382 shares at $21.88 ($2.4M) on 2025-12-16, disclosed to the SEC on 2025-12-18.
Scheduled sale ($2.4M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.88 | 28,947 | $633K | 26.3% |
| 2 | $21.88 | 28,947 | $633K | 26.3% |
| 3 | $22.16 | 25,744 | $570K | 23.7% |
| 4 | $22.16 | 25,744 | $570K | 23.7% |
| Total | $22.01 avg | 109,382 | $2.4M | 100% |
| Filing → |
| RCUS | SELL | 2022-06-21 | $350K | — | Filing → |
| RCUS | SELL | 2021-12-20 | $277K | — | Filing → |
| RCUS | SELL | 2021-06-21 | $418K | — | Filing → |